TuHURA Biosciences, Inc.
1.3M
$188.19M
-1.21
$-0.63
No price alerts set. Add an alert to get notified!
-1.21
1.73
$-0.63
-143.61%
0.00%
0.00%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
ABOS
Acumen Pharmaceuticals, Inc.
|
$2.69 | -1.10% | -1.34 | $162.94M | 0.44 |
|
AGEN
Agenus Inc.
|
$4.64 | -3.93% | 1,425.10 | $178.17M | -1.24 |
|
CGTX
Cognition Therapeutics, Inc.
|
$1.11 | 1.83% | -4.20 | $81.68M | 0.02 |
|
INO
Inovio Pharmaceuticals, Inc.
|
$1.16 | -2.52% | -6.40 | $62.16M | 0.39 |
|
IRD
Opus Genetics, Inc.
|
$5.75 | 0.70% | -72.15 | $409.11M | 0.00 |
|
MCRB
Seres Therapeutics, Inc.
|
$8.83 | -0.11% | 13.73 | $84.65M | 1.88 |
|
SEER
Seer, Inc.
|
$2.05 | 4.59% | -1.60 | $115.66M | 0.09 |
|
SPRO
Spero Therapeutics, Inc.
|
$2.68 | 1.52% | 17.51 | $155.15M | 0.05 |
|
TVGN
Tevogen Bio Holdings Inc.
|
$6.36 | -1.24% | -0.80 | $26.48M | -0.38 |
|
VTGN
VistaGen Therapeutics, Inc.
|
$0.60 | -1.36% | -0.38 | $19.77M | 0.03 |
* Peer stocks are selected based on market capitalization and sector
$4.44
$0.41
$0.00
0.02%
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
